Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: ARISAN THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-22 to 2025-12-31
Current total value of award: $3692037
Description: TO CONDUCT NON-CLINICAL GOOD LABORATORY PRACTICE (GLP) IN VIVO GENOTOXICITY AND REPRODUCTIVE TOXICOLOGY AND GLP DEVELOPMENT AND REPRODUCTIVE (DART) TOXICOLOGY STUDIES.